Home Who we are Services Events Case history Contacts Tel. +39 0363 184 8776 | Mail: segreteria@materia1a.it IT EN Filter by categories: All Aesthetic medicine Surgery Other Event organization Tel: +39 0363 184 8776 Mail: segreteria@materia1a.it see detail 14/11/2020 - 14/12/2020 # REUMAHUMANTAS2020: regional pain in rheumatology # REUMAHUMANTAS2020: the pain ... La reumatologia è una disciplina di grande complessità clinica che comprende malattie sistemiche con infiammazione cronica dai meccanismi immunologici comuni e che spesso pone importanti quesiti diagn... vedi dettaglio 22/10/2020 - 23/10/2020 TaTME - X Ed. TaTME - X Ed. Our workshop is aimed at colorectal surgeons experienced in laparoscopic and/or robotic rectal surgery, and ideally also experienced with transanal surgery, especially TEM and TAMIS. This 2-day course... vedi dettaglio 05/10/2020 A NEW LOOK AT TREAT TO TARGET STRATEGIES IN CROHN’S DISEASE A NEW LOOK AT TREAT TO TARGE... Inflamma tory bowel disease (I BD) including Cro hn’s di s ease (CD) and Ulcerative Coli tis (UC) are chronic diseases t hat significantly impact on patients' lives. Novel diagnostic and interventiona... vedi dettaglio 02/10/2020 - 14/02/2021 CORSO AIDMOV DRENAGGIO LINFATICO - ORIGINALMETHODE Vodder CORSO AIDMOV DRENAGGIO LINFA... Il linfedema si manifesta clinicamente con un aumento di volume che coinvolge più frequentemente gli arti. Si tratta di una patologia cronica in cui si ha l’accumulo di fluido ricco in proteine negli ... vedi dettaglio 28/09/2020 - 08/10/2020 OPTIMIZE MILD-MODERATE UC ACADEMY OPTIMIZE MILD-MODERATE UC AC... The aim of the webinar is how to optimize treatments on patients with moderate mild ulcerative rectocolitis using the mostmodern therapy strategies such as mesalazine or budesonide mmx.A total of 9 ca... vedi dettaglio 19/09/2020 INFLIXIMAB TREATMENT IN IBD: FROM THEORY TO CLINICAL PRACTICE INFLIXIMAB TREATMENT IN IBD:... Biosimilars are increasingly used to treat ibd patients. Subcutaneous infliximab is now available in IBD. As intra venous infliximab can be used for every ibd patient refractory to standard treatment... See More Raw Materials Legal and operational headquarters: Via Abate Crippa, 19 - 24047 Treviglio (BG) Tel: +39 0363 184 8776 - Fax +39 03631920301 - Email: segreteria@materia1a.it VAT number 03797550161 - Reg. of BG n. 409449 - Share Capital € 10,000 Privacy | Cookie © 2020 - powered by CoriWeb & Qcom Disclosure This site or third-party tools used by this make use of cookies necessary for the operation and useful for the purposes described in the cookie policy. If you want to learn more or opt out of all or some cookies, consult the cookie policy. By clicking on 'Accept', continuing to browse or scrolling this page or ignoring this banner, you consent to the installation of cookies. More information I accept